metoclopramide has been researched along with Hyperprolactinemia in 80 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The response profile of total and monomeric prolactin following the administration of metoclopramide was similar in women with monomeric hyperprolactinemia and normoprolactinemia but different in women with macroprolactinemia." | 7.85 | Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia. ( Calaf, J; Espinós, JJ; Gich, I; Urgell, E; Vanrell, C, 2017) |
| "The aim of this study was to evaluate the effects of metoclopramide-induced hyperprolactinemia on the prolactin (PRL) and prolactin receptor's (PRLR) expression in the adrenal." | 7.81 | Effects of metoclopramide-induced hyperprolactinemia on the prolactin and prolactin receptor expression of murine adrenal. ( Baracat, EC; Carvalho, KC; da Silva, PL; do Amaral, VC; Maciel, GA; Simoncini, T; Soares, JM, 2015) |
| "In this work we have evaluated the gene expression profile of prolactin and prolactin receptor in the pituitary and the uterus of female mice with metoclopramide-induced hyperprolactinemia treated with estrogen and/or progesterone." | 7.79 | Metoclopramide-induced hyperprolactinemia effects on the pituitary and uterine prolactin receptor expression. ( Amaral, VC; Baracat, EC; Carvalho, KC; Maciel, GA; Marcondes, RR; Soares, JM, 2013) |
| "To evaluate the effects of metoclopramide-induced hyperprolactinemia on the prolactin receptor of murine endometrium." | 7.76 | Effects of metoclopramide-induced hyperprolactinemia on the prolactin receptor of murine endometrium. ( Baracat, EC; de Jesus Simões, M; Dos Santos Simões, R; Oliveira, PB; Rossi, AG; Soares, JM; Teixeira Gomes, RC, 2010) |
| "Evaluation of metoclopramide (MTC) test values in end-stage renal disease patients undergoing hemodialysis with different level of hyperprolactinemia was aim of the study." | 7.73 | [Metoclopramide test in the patients with hyperprolactinemia due to end-stage renal failure]. ( Gomółka, M; Grochowski, J; Kulicki, P; Matuszkiewicz-Rowńska, J; Niemczyk, L; Niemczyk, S; Ostrowski, G; Sitkowska-Kurzec, Z; Stopiński, M; Szamotulska, K, 2006) |
| "The cells with nuclear DNA fragmentation related to apoptosis were detected by TUNEL technique in the seminiferous epithelium of control rats and of rats with experimental hyperprolactinemia induced by metoclopramide." | 7.71 | Germ cells with nuclear DNA fragmentation related to apoptotic cells in rat testis in experimental hyperprolactinemia induced by metoclopramide. ( Debińska-Szymańska, T; Laszczyńska, M; Piasecka, M; Skowron, J; Słuczanowska-Głabowska, S, 2002) |
| "Diffuse hemangiomatosis of the liver became apparent in a 22-year-old woman while she was receiving medication with metoclopramide and experiencing the well-known adverse effect of the drug, hyperprolactinemia with secondary amenorrhea and galactorrhea." | 7.68 | Arteriovenous shunting and cholestasis in hepatic hemangiomatosis associated with metoclopramide. ( Feurle, GE, 1990) |
| "The aim of the performed studies has been to find out wether or not the ultrastructural alterations of the epithelial cells in the rat's epididymal caput occur in hyperprolactinemia induced by metoclopramide and to see if the observed changes are of reversible character." | 7.67 | Ultrastructure of epithelial cells in rat's epididymal caput in experimental hyperprolactinemia induced by metoclopramide. ( Laszczyńska, M; Lubiński, J; Rózewicka, L, 1989) |
| " We have compared the TSH and PRL responses to metoclopramide (MCP) in normal and postpartum lactating women with those in 28 patients with hyperprolactinemia of different origin." | 7.67 | Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients. ( Anile, C; Barbarino, A; De Marinis, L; Maira, G; Mancini, A; Masala, R; Minnielli, S, 1985) |
| "The ergoline derivative, Metergoline, in a dosage of 4 to 24 mg/day, was administered for one to eight months to 42 patients with hyperprolactinemic amenorrhea." | 7.67 | Treatment of hyperprolactinemic amenorrhea with Metergoline. ( Bohnet, HG; Kato, K; Wolf, AS, 1986) |
| "Present study was performed to investigate whether TRH or metoclopramide (MCP) loading test was useful for the diagnosis of so-called occulted or latent hyperprolactinemia (transient increase of serum prolactin levels more than 30 ng/ml during night; OHP)." | 7.67 | [Role of TRH or metoclopramide loading test in the diagnosis of so-called occult or latent hyperprolactinemia]. ( Aisaka, K; Ando, S; Kaneda, S; Kokuho, K; Mori, H; Tawada, T; Yoshida, K, 1987) |
| "The impact of hyperprolactinaemia on endometrial function, along with embryo implantation, has been the subject of discussion." | 5.33 | Metoclopramide-induced hyperprolactinaemia caused marked decline in pinopodes and pregnancy rates in mice. ( Baptista, HA; Baracat, EC; da Motta, EL; de Jesus Simões, M; Haapalainen, EF; Haidar, MA; Júnior, JM; Panzan, MQ, 2006) |
| "The patients with microprolactinomas had a low prolactin response (increments less than 300-400%) and delayed TSH response." | 5.28 | [Pharmacodynamic metoclopramide (cerucal) test in differential diagnosis of hypoprolactinemic hypogonadism syndrome in women]. ( Balabolkin, MI; Gerasimov, GA; Liubimov, AV, 1990) |
| "Pretreatment with metoclopramide enhanced the CRH-induced cortisol increase from 30-120 min after CRH in normal men, but only at 15 and 30 min in 5 agromegalic patients." | 5.27 | Pituitary-adrenocortical response to metoclopramide in patients with acromegaly and prolactinoma: a clinical evaluation of catecholamine-mediated adrenocorticotropin secretion. ( Adachi, N; Endoh, M; Horino, M; Ishii, R; Kikuoka, M; Matsuki, M; Nishida, S; Otsuka, R; Oyama, H; Yoneda, M, 1987) |
| "Induced hyperprolactinaemia impairs ovarian follicular development, especially during the recruitment period." | 5.27 | Metoclopramide-induced hyperprolactinaemia: effects on corpus luteum function, endometrial steroid receptor concentrations and 17 beta-hydroxysteroid dehydrogenase activity. ( Isotalo, H; Kauppila, A; Kirkinen, P; Mäkilä, UM; Orava, M; Vihko, R, 1987) |
| " Women in the bromocriptine group (except manifestly hyperprolactinaemic patients) had significantly higher pregnancy rates than those not treated with bromocriptine." | 5.07 | [Value of the metoclopramide test in diagnosis of hormonal causes of female sterility]. ( Gerhard, I; Matt, O; Runnebaum, B, 1992) |
| "To investigate the effects of acute hyperprolactinemia on the 24 h LH pulsatile pattern, 11 women in the early follicular phase (EF, days 3 and 4) and 8 postmenopausal women (PMW) were studied before and during administration of metoclopramide, a dopamine receptor antagonist." | 5.06 | Effects of acute hyperprolactinemia on LH pulsatile secretion in hypogonadal and early follicular phase women. ( Mortola, JF; Rossmanith, WG; Yen, SS, 1988) |
| "YRTJ Granule ameliorated metoclopramide-induced hyperprolactinemia in rats." | 3.85 | Paeoniflorin and liquiritin, two major constituents in Chinese herbal formulas used to treat hyperprolactinemia-associated disorders, inhibits prolactin secretion in prolactinoma cells by different mechanisms. ( Batey, R; La, L; Li, Y; Wang, C; Wang, L; Wei, Y, 2017) |
| "The response profile of total and monomeric prolactin following the administration of metoclopramide was similar in women with monomeric hyperprolactinemia and normoprolactinemia but different in women with macroprolactinemia." | 3.85 | Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia. ( Calaf, J; Espinós, JJ; Gich, I; Urgell, E; Vanrell, C, 2017) |
| "The aim of this study was to evaluate the effects of metoclopramide-induced hyperprolactinemia on the tibial epiphyseal plate of hormone-treated oophorectomized mice." | 3.83 | Effects of hyperprolactinemia on the tibial epiphyseal plate of mice treated with sex hormones. ( Baracat, EC; da Silva, PL; do Amaral, VC; Gomes, RC; Prosdocimi, FC; Simões, MJ; Simoes, RS; Simoncini, T; Soares, JM; Wolff, RB, 2016) |
| "The aim of this study was to evaluate the effects of metoclopramide-induced hyperprolactinemia on the prolactin (PRL) and prolactin receptor's (PRLR) expression in the adrenal." | 3.81 | Effects of metoclopramide-induced hyperprolactinemia on the prolactin and prolactin receptor expression of murine adrenal. ( Baracat, EC; Carvalho, KC; da Silva, PL; do Amaral, VC; Maciel, GA; Simoncini, T; Soares, JM, 2015) |
| "In this work we have evaluated the gene expression profile of prolactin and prolactin receptor in the pituitary and the uterus of female mice with metoclopramide-induced hyperprolactinemia treated with estrogen and/or progesterone." | 3.79 | Metoclopramide-induced hyperprolactinemia effects on the pituitary and uterine prolactin receptor expression. ( Amaral, VC; Baracat, EC; Carvalho, KC; Maciel, GA; Marcondes, RR; Soares, JM, 2013) |
| "hyperprolactinemia (MIHP) was induced by administration of metoclopramide dihydrochloride (50 mg/kg, tid, ip, for 10 d) in SD rats and the primary pituitary cells were prepared from the pituitary glands of the SD rats." | 3.76 | Casticin, a flavonoid isolated from Vitex rotundifolia, inhibits prolactin release in vivo and in vitro. ( QIN, LP; WANG, Y; YE, Q; ZHANG, QY; ZHENG, CJ, 2010) |
| "To evaluate the effects of metoclopramide-induced hyperprolactinemia on the prolactin receptor of murine endometrium." | 3.76 | Effects of metoclopramide-induced hyperprolactinemia on the prolactin receptor of murine endometrium. ( Baracat, EC; de Jesus Simões, M; Dos Santos Simões, R; Oliveira, PB; Rossi, AG; Soares, JM; Teixeira Gomes, RC, 2010) |
| "Evaluation of metoclopramide (MTC) test values in end-stage renal disease patients undergoing hemodialysis with different level of hyperprolactinemia was aim of the study." | 3.73 | [Metoclopramide test in the patients with hyperprolactinemia due to end-stage renal failure]. ( Gomółka, M; Grochowski, J; Kulicki, P; Matuszkiewicz-Rowńska, J; Niemczyk, L; Niemczyk, S; Ostrowski, G; Sitkowska-Kurzec, Z; Stopiński, M; Szamotulska, K, 2006) |
| "The cells with nuclear DNA fragmentation related to apoptosis were detected by TUNEL technique in the seminiferous epithelium of control rats and of rats with experimental hyperprolactinemia induced by metoclopramide." | 3.71 | Germ cells with nuclear DNA fragmentation related to apoptotic cells in rat testis in experimental hyperprolactinemia induced by metoclopramide. ( Debińska-Szymańska, T; Laszczyńska, M; Piasecka, M; Skowron, J; Słuczanowska-Głabowska, S, 2002) |
| "The metoclopramide test for latent hyperprolactinaemia was done on 174 randomly chosen infertile women in the midfollicular phase of the cycle." | 3.69 | The influence of latent hyperprolactinaemia on the levels of LH, FSH, E2 and T in the midfollicular phase of the cycle. ( Kostál, M; Tosner, J, 1997) |
| "The objective was to define the diagnostic validity of prolactin response tests by comparing the stimulating effect of thyrotropin-releasing hormone (TRH) and metoclopramide on prolactin secretion in patients with and without functional hyperprolactinemia." | 3.69 | Prolactin response to metoclopramide and thyrotropin-releasing hormone in normoprolactinemic and hyperprolactinemic women: a comparison of diagnostic validity. ( Brosemann, N; Bussen, S; Steck, T, 1996) |
| " The determination of prolactin concentration after the administration of metoclopramide made possible the diagnosis of functional hyperprolactinaemia." | 3.68 | [A case of functional hyperprolactinemia]. ( Kapłon, E; Przybyłowski, J; Siedlecki, J, 1992) |
| "A 21 year old female treated for recurring gastric troubles with dopamine-antagonists (domperidone, metoclopramide) developed a clinically manifest hyperprolactinemia (3055 microU/l; normal value < 650 microU/l) with galactorrhea only two days after a new two day course of metoclopramide." | 3.68 | [Drug-induced hyperprolactinemia and galactorrhea]. ( Bozzolo, M; Haefeli, WE; Lüscher, TF; Noll, G, 1992) |
| "Diffuse hemangiomatosis of the liver became apparent in a 22-year-old woman while she was receiving medication with metoclopramide and experiencing the well-known adverse effect of the drug, hyperprolactinemia with secondary amenorrhea and galactorrhea." | 3.68 | Arteriovenous shunting and cholestasis in hepatic hemangiomatosis associated with metoclopramide. ( Feurle, GE, 1990) |
| "The aim of the performed studies has been to find out wether or not the ultrastructural alterations of the epithelial cells in the rat's epididymal caput occur in hyperprolactinemia induced by metoclopramide and to see if the observed changes are of reversible character." | 3.67 | Ultrastructure of epithelial cells in rat's epididymal caput in experimental hyperprolactinemia induced by metoclopramide. ( Laszczyńska, M; Lubiński, J; Rózewicka, L, 1989) |
| " Furthermore, to evaluate whether high circulating PRL levels influence the activity of the opioid system after the menopause, a group of seven postmenopausal subjects was tested before and 1 week after the administration of metoclopramide (10 mg, three times a day), a dopamine receptor antagonist." | 3.67 | Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states. ( Brambilla, F; De Leo, V; Facchinetti, F; Genazzani, AR; Montemagno, U; Nappi, C; Petraglia, F, 1987) |
| " With the TRH-MC test, Prl responses to TRH and MC were significantly lowered in amenorrhoea (N = 8) and hyperprolactinaemia (N = 15) regardless of whether or not treated with bromocriptine, and to MC only in oligomenorrhoea (n = 11)." | 3.67 | Dynamic evaluation of prolactin secretion by successive TRH and metoclopramide stimulations. ( Heikkinen, J; Kauppila, A; Viinikka, L, 1986) |
| "Present study was performed to investigate whether TRH or metoclopramide (MCP) loading test was useful for the diagnosis of so-called occulted or latent hyperprolactinemia (transient increase of serum prolactin levels more than 30 ng/ml during night; OHP)." | 3.67 | [Role of TRH or metoclopramide loading test in the diagnosis of so-called occult or latent hyperprolactinemia]. ( Aisaka, K; Ando, S; Kaneda, S; Kokuho, K; Mori, H; Tawada, T; Yoshida, K, 1987) |
| "The ergoline derivative, Metergoline, in a dosage of 4 to 24 mg/day, was administered for one to eight months to 42 patients with hyperprolactinemic amenorrhea." | 3.67 | Treatment of hyperprolactinemic amenorrhea with Metergoline. ( Bohnet, HG; Kato, K; Wolf, AS, 1986) |
| "In order to determine whether endogenous dopaminergic tone has any role in the diurnal variation in TSH secretion, the 24-h secretory pattern of TSH and the TSH response to a dopamine antagonist, metoclopramide (MCP), were evaluated in normal women (n = 4) and in hyperprolactinemic-amenorrheic women with pituitary microadenoma (n = 6)." | 3.67 | Twenty-four hour secretory pattern of thyroid-stimulating hormone in hyperprolactinemic women with pituitary microadenoma. ( Kato, K; Seki, K; Shima, K; Uesato, T, 1985) |
| " We have compared the TSH and PRL responses to metoclopramide (MCP) in normal and postpartum lactating women with those in 28 patients with hyperprolactinemia of different origin." | 3.67 | Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients. ( Anile, C; Barbarino, A; De Marinis, L; Maira, G; Mancini, A; Masala, R; Minnielli, S, 1985) |
| "Group C- 70 patients with FAI<5 and irregular menstruation, group D - 65 patients with FAI<5 and regular menstruation." | 1.51 | Basal and metoclopramide induced prolactin secretion in lean PCOS women. ( Dabrowski, FA; Doroszewska, K; Gałuszka-Bednarczyk, A; Guzik, J; Janeczko, M; Kiałka, M; Marianowski, P; Milewicz, T; Mrozinska, S; Przywara-Sikora, A, 2019) |
| "Selfheal extract treated hyperprolactinemia through dopamine D2 receptor with significant effect." | 1.46 | The mechanism of selfheal extract in treating hyperprolactinemia. ( Luan, S; Mu, M; Sun, L, 2017) |
| "Hyperprolactinemia was closely correlated with HMG, and hyperprolactinemia promoted the formation of HMG." | 1.39 | Effect of Chinese medical herbs-Huiru Yizeng Yihao on hyperprolactinemia and hyperplasia of mammary gland in mice. ( Chen, YG; Li, JY; Li, ZH; Liu, XG; Ma, L; Wang, X; Wu, JH; Zou, JL, 2013) |
| "The impact of hyperprolactinaemia on endometrial function, along with embryo implantation, has been the subject of discussion." | 1.33 | Metoclopramide-induced hyperprolactinaemia caused marked decline in pinopodes and pregnancy rates in mice. ( Baptista, HA; Baracat, EC; da Motta, EL; de Jesus Simões, M; Haapalainen, EF; Haidar, MA; Júnior, JM; Panzan, MQ, 2006) |
| "Hyperprolactinemia has been found in patients with systemic lupus erythematosus (SLE) and seems to be associated with clinical activity." | 1.32 | Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin. ( Alarcón-Segovia, D; Alcocer-Varela, J; de la Cruz, DA; Larrea, F; Lava-Zavala, A; Méndez, I; Parra, A, 2004) |
| "The effect of hyperprolactinaemia on the prostate has still not been fully elucidated." | 1.32 | The expression of androgen receptors in the epithelial cells of the rat prostate lateral lobe in experimental hyperprolactinaemia: a morphological and immunohistochemical study. ( Kram, A; Laszczyńska, M; Piasecka, M; Słuczanowska-Głabowska, S; Wylot, M, 2003) |
| "Estrone (E1) was assayed by means of "DBC Diagnostic kits." | 1.31 | [The concentrations of prolactin and estrogens in women with fibrocystic changes in the breast]. ( Sieja, K; Stanosz, S, 2002) |
| "The patients with microprolactinomas had a low prolactin response (increments less than 300-400%) and delayed TSH response." | 1.28 | [Pharmacodynamic metoclopramide (cerucal) test in differential diagnosis of hypoprolactinemic hypogonadism syndrome in women]. ( Balabolkin, MI; Gerasimov, GA; Liubimov, AV, 1990) |
| "Galactorrhea was associated with the following conditions: hyperprolactinemia (34." | 1.28 | [The value of hyperprolactinemia determination within the scope of galactorrhea]. ( Enzelsberger, H; Kubista, E; Schurz, B; Wenzl, R, 1989) |
| "Pretreatment with metoclopramide enhanced the CRH-induced cortisol increase from 30-120 min after CRH in normal men, but only at 15 and 30 min in 5 agromegalic patients." | 1.27 | Pituitary-adrenocortical response to metoclopramide in patients with acromegaly and prolactinoma: a clinical evaluation of catecholamine-mediated adrenocorticotropin secretion. ( Adachi, N; Endoh, M; Horino, M; Ishii, R; Kikuoka, M; Matsuki, M; Nishida, S; Otsuka, R; Oyama, H; Yoneda, M, 1987) |
| "Induced hyperprolactinaemia impairs ovarian follicular development, especially during the recruitment period." | 1.27 | Metoclopramide-induced hyperprolactinaemia: effects on corpus luteum function, endometrial steroid receptor concentrations and 17 beta-hydroxysteroid dehydrogenase activity. ( Isotalo, H; Kauppila, A; Kirkinen, P; Mäkilä, UM; Orava, M; Vihko, R, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (35.00) | 18.7374 |
| 1990's | 19 (23.75) | 18.2507 |
| 2000's | 16 (20.00) | 29.6817 |
| 2010's | 17 (21.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mrozinska, S | 1 |
| Przywara-Sikora, A | 1 |
| Doroszewska, K | 1 |
| Gałuszka-Bednarczyk, A | 1 |
| Kiałka, M | 1 |
| Guzik, J | 1 |
| Janeczko, M | 1 |
| Marianowski, P | 1 |
| Dabrowski, FA | 1 |
| Milewicz, T | 1 |
| Wei, Y | 1 |
| La, L | 1 |
| Wang, L | 1 |
| Batey, R | 1 |
| Wang, C | 1 |
| Li, Y | 1 |
| Luan, S | 1 |
| Mu, M | 1 |
| Sun, L | 1 |
| Tabrizi, SO | 1 |
| Mirghafourvand, M | 1 |
| Dost, AJ | 1 |
| Mohammad-Alizadeh-Charandabi, S | 1 |
| Javadzadeh, Y | 1 |
| Seyedi, R | 1 |
| Amaral, VC | 1 |
| Maciel, GA | 2 |
| Carvalho, KC | 2 |
| Marcondes, RR | 1 |
| Soares, JM | 7 |
| Baracat, EC | 9 |
| Gomes, RC | 4 |
| Maioral, GC | 1 |
| Verna, C | 3 |
| Patriarca, MT | 1 |
| Nader, HB | 1 |
| Simões, RS | 4 |
| Wang, X | 1 |
| Chen, YG | 1 |
| Ma, L | 1 |
| Li, ZH | 1 |
| Li, JY | 1 |
| Liu, XG | 1 |
| Zou, JL | 1 |
| Wu, JH | 1 |
| Wolff, RB | 2 |
| do Amaral, VC | 2 |
| da Silva, PL | 2 |
| Simoncini, T | 2 |
| Prosdocimi, FC | 1 |
| Simões, MJ | 2 |
| Wang, D | 2 |
| Wang, W | 1 |
| Zhou, Y | 1 |
| Wang, J | 1 |
| Jia, D | 1 |
| Wong, HK | 2 |
| Zhang, ZJ | 2 |
| Araujo, AS | 1 |
| Simões, Mde J | 1 |
| Soares Júnior, JM | 1 |
| Espinós, JJ | 1 |
| Vanrell, C | 1 |
| Gich, I | 1 |
| Urgell, E | 1 |
| Calaf, J | 1 |
| Niemczyk, S | 1 |
| Matuszkiewicz-Rowńska, J | 1 |
| Szamotulska, K | 1 |
| Sitkowska-Kurzec, Z | 1 |
| Gomółka, M | 1 |
| Stopiński, M | 1 |
| Grochowski, J | 1 |
| Niemczyk, L | 1 |
| Ostrowski, G | 1 |
| Kulicki, P | 1 |
| Nag', IuG | 1 |
| Rossi, AG | 2 |
| Teixeira Gomes, RC | 1 |
| de Jesus Simões, M | 2 |
| Dos Santos Simões, R | 1 |
| Oliveira, PB | 1 |
| YE, Q | 1 |
| ZHANG, QY | 1 |
| ZHENG, CJ | 1 |
| WANG, Y | 1 |
| QIN, LP | 1 |
| Słuczanowska-Głąbowska, S | 5 |
| Laszczyńska, M | 5 |
| Wylot, M | 3 |
| Głąbowski, W | 2 |
| Piasecka, M | 3 |
| Gącarzewicz, D | 1 |
| Zhang, L | 1 |
| McAlonan, GM | 1 |
| Wang, XM | 1 |
| Sze, SC | 1 |
| Feng, YB | 1 |
| Sieja, K | 1 |
| Stanosz, S | 1 |
| Leaños-Miranda, A | 1 |
| Contreras-Hernández, I | 1 |
| Motta, EL | 1 |
| Oliveira-Filho, RM | 1 |
| Haidar, MA | 2 |
| Rodrigues de Lima, G | 1 |
| Kram, A | 1 |
| Méndez, I | 1 |
| Alcocer-Varela, J | 1 |
| Parra, A | 1 |
| Lava-Zavala, A | 1 |
| de la Cruz, DA | 1 |
| Alarcón-Segovia, D | 1 |
| Larrea, F | 2 |
| Noczyńska, A | 1 |
| Wasikowa, R | 1 |
| Panzan, MQ | 1 |
| Júnior, JM | 1 |
| da Motta, EL | 1 |
| Haapalainen, EF | 1 |
| Baptista, HA | 1 |
| Hattori, N | 1 |
| Nakayama, Y | 1 |
| Kitagawa, K | 1 |
| Li, T | 1 |
| Inagaki, C | 1 |
| Edwards, L | 1 |
| Seki, K | 4 |
| Mitsui, C | 1 |
| Nagata, I | 1 |
| Verhelst, J | 1 |
| Beckers, A | 1 |
| Abs, R | 1 |
| Walsh, JP | 1 |
| Bhagat, CI | 1 |
| Pullan, PT | 1 |
| Rampono, JG | 1 |
| Corbett, T | 1 |
| de Takats, D | 1 |
| Tattersall, JE | 1 |
| Greenwood, RN | 1 |
| Farrington, K | 1 |
| Bjøro, T | 1 |
| Johansen, E | 1 |
| Frey, HH | 1 |
| Turter, A | 1 |
| Torjesen, PA | 1 |
| Bussen, S | 1 |
| Brosemann, N | 1 |
| Steck, T | 1 |
| Kostál, M | 1 |
| Tosner, J | 1 |
| Azuma, K | 1 |
| Irahara, M | 1 |
| Aono, T | 3 |
| Moro, M | 1 |
| Maraschini, C | 1 |
| Cavagnini, F | 1 |
| Alvarez-Tutor, E | 1 |
| Forga-LLenas, L | 1 |
| Rodriguez-Erdozain, R | 1 |
| Goñi-Iriarte, MJ | 1 |
| Mendendez-Torre, E | 1 |
| Alvarez-Tutor, J | 1 |
| Lissoni, P | 1 |
| Mandalà, M | 1 |
| Rovelli, F | 1 |
| Casu, M | 1 |
| Rocco, F | 1 |
| Tancini, G | 1 |
| Scardino, E | 1 |
| Snowden, H | 1 |
| Woolridge, M | 1 |
| Renfrew, M | 1 |
| Skowron, J | 1 |
| Debińska-Szymańska, T | 1 |
| Przybyłowski, J | 1 |
| Siedlecki, J | 1 |
| Kapłon, E | 1 |
| Bozzolo, M | 1 |
| Haefeli, WE | 1 |
| Noll, G | 1 |
| Lüscher, TF | 1 |
| Matt, O | 1 |
| Gerhard, I | 1 |
| Runnebaum, B | 1 |
| Gerasimov, G | 1 |
| Chernova, T | 1 |
| Goncharov, N | 1 |
| Yamaguchi, M | 1 |
| Koike, K | 1 |
| Nishikawa, Y | 1 |
| Ikegami, H | 1 |
| Miyake, A | 2 |
| Tanizawa, O | 2 |
| Klockenbusch, W | 1 |
| Distler, W | 1 |
| von Ditfurth, M | 1 |
| Graf, M | 1 |
| Jahn, K | 1 |
| Reinthaller, A | 1 |
| Neunteufel, W | 1 |
| Bieglmayer, C | 1 |
| Fischl, F | 1 |
| Balabolkin, MI | 1 |
| Gerasimov, GA | 1 |
| Liubimov, AV | 1 |
| Feurle, GE | 1 |
| Schurz, B | 1 |
| Enzelsberger, H | 1 |
| Kubista, E | 1 |
| Wenzl, R | 1 |
| Anderson, PW | 1 |
| Malarkey, WB | 1 |
| Salk, J | 1 |
| Kletsky, OA | 1 |
| Hsueh, WA | 1 |
| Chen, CF | 1 |
| Kurachi, H | 1 |
| Caruso, A | 1 |
| Lanzone, A | 1 |
| Fulghesu, AM | 1 |
| Apa, R | 1 |
| Guida, C | 1 |
| Mancuso, S | 1 |
| Rózewicka, L | 1 |
| Lubiński, J | 1 |
| Kauppila, A | 2 |
| Isotalo, H | 1 |
| Kirkinen, P | 1 |
| Mäkilä, UM | 1 |
| Orava, M | 1 |
| Vihko, R | 1 |
| Petraglia, F | 1 |
| De Leo, V | 1 |
| Nappi, C | 1 |
| Facchinetti, F | 1 |
| Montemagno, U | 1 |
| Brambilla, F | 1 |
| Genazzani, AR | 1 |
| Langner, TK | 1 |
| Mel'nichenko, GA | 1 |
| Dedov, II | 1 |
| Saakian, OA | 1 |
| Gitel', EP | 1 |
| Nishida, S | 1 |
| Matsuki, M | 1 |
| Adachi, N | 1 |
| Horino, M | 1 |
| Yoneda, M | 1 |
| Endoh, M | 1 |
| Oyama, H | 1 |
| Kikuoka, M | 1 |
| Otsuka, R | 1 |
| Ishii, R | 1 |
| Heikkinen, J | 1 |
| Viinikka, L | 1 |
| Scott, JS | 1 |
| Lakin, CA | 1 |
| Oliver, JR | 1 |
| Aisaka, K | 1 |
| Ando, S | 1 |
| Kokuho, K | 1 |
| Kaneda, S | 1 |
| Tawada, T | 1 |
| Yoshida, K | 1 |
| Mori, H | 1 |
| Carol, W | 1 |
| Lauterbach, H | 1 |
| Klinger, G | 1 |
| Unger, A | 1 |
| Michels, W | 1 |
| Porias Cuéllas, HL | 1 |
| Hernández Bueno, JA | 1 |
| Villanueva, C | 1 |
| Benavides, S | 1 |
| Cortés-Gallegos, V | 1 |
| Serri, O | 2 |
| Beauregard, H | 1 |
| Somma, M | 1 |
| Comtois, R | 1 |
| Jilwan, N | 1 |
| Hardy, J | 1 |
| Rossmanith, WG | 1 |
| Mortola, JF | 1 |
| Yen, SS | 1 |
| Day, JO | 1 |
| Escorza, A | 1 |
| Granados, J | 1 |
| Valencia, X | 1 |
| Valero, A | 1 |
| Cravioto, MC | 1 |
| Pérez-Palacios, G | 1 |
| Torres-Noriega, J | 1 |
| Frohman, LA | 1 |
| Aguirre Sánchez-Covisa, M | 1 |
| Ruiz-Valdepeñas, MP | 1 |
| Larrodera, L | 1 |
| Jaunsolo, MA | 1 |
| Hawkins, FG | 1 |
| Kato, K | 4 |
| Shima, K | 2 |
| O'Malley, BP | 1 |
| Mercey, D | 1 |
| Clarke, E | 1 |
| Maguire, M | 1 |
| Jackson, J | 1 |
| Rosenthal, FD | 1 |
| Bohnet, HG | 1 |
| Wolf, AS | 1 |
| Uesato, T | 1 |
| De Marinis, L | 1 |
| Mancini, A | 1 |
| Minnielli, S | 1 |
| Masala, R | 1 |
| Anile, C | 1 |
| Maira, G | 1 |
| Barbarino, A | 1 |
| Petersen, H | 1 |
| Münster, K | 1 |
| Nielsen, LH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Role of Nesfatin-1 and Nicotinamide in Infertile Women With Polycystic Ovary Syndrome[NCT03870035] | 56 participants (Anticipated) | Observational | 2019-05-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for metoclopramide and Hyperprolactinemia
| Article | Year |
|---|---|
[Metoclopramide, sulpiride, and chlorpromazine loading test].
Topics: Chlorpromazine; Humans; Hyperprolactinemia; Metoclopramide; Pituitary Function Tests; Pituitary Glan | 1997 |
5 trials available for metoclopramide and Hyperprolactinemia
| Article | Year |
|---|---|
Effect of metoclopramide administration to mothers on neonatal bilirubin and maternal prolactin: a randomized, controlled, clinical trial.
Topics: Blood Chemical Analysis; Breast Feeding; Chi-Square Distribution; Double-Blind Method; Female; Follo | 2019 |
Dopamine infusion enhances the adrenocorticotropic hormone and cortisol response to metoclopramide in hyperprolactinemic patients but not in normal subjects.
Topics: Adrenocorticotropic Hormone; Adult; Dopamine; Dopamine Antagonists; Female; Humans; Hydrocortisone; | 1997 |
[Value of the metoclopramide test in diagnosis of hormonal causes of female sterility].
Topics: Adult; Bromocriptine; Female; Gonadal Steroid Hormones; Humans; Hyperprolactinemia; Infertility, Fem | 1992 |
Effect of luteal metoclopramide-induced hyperprolactinemia on pituitary and luteal responsiveness to gonadotropin-releasing hormone.
Topics: Adult; Corpus Luteum; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; L | 1989 |
Effects of acute hyperprolactinemia on LH pulsatile secretion in hypogonadal and early follicular phase women.
Topics: Adult; Algorithms; Female; Follicular Phase; Humans; Hyperprolactinemia; Luteinizing Hormone; Menopa | 1988 |
74 other studies available for metoclopramide and Hyperprolactinemia
| Article | Year |
|---|---|
Basal and metoclopramide induced prolactin secretion in lean PCOS women.
Topics: Administration, Oral; Adult; Diagnostic Techniques, Endocrine; Female; Humans; Hyperprolactinemia; M | 2019 |
Paeoniflorin and liquiritin, two major constituents in Chinese herbal formulas used to treat hyperprolactinemia-associated disorders, inhibits prolactin secretion in prolactinoma cells by different mechanisms.
Topics: Animals; Cell Line, Tumor; Drugs, Chinese Herbal; Female; Flavanones; Glucosides; Hyperprolactinemia | 2017 |
The mechanism of selfheal extract in treating hyperprolactinemia.
Topics: Animals; Cell Line; Dopamine Plasma Membrane Transport Proteins; Drugs, Chinese Herbal; Female; Horm | 2017 |
Metoclopramide-induced hyperprolactinemia effects on the pituitary and uterine prolactin receptor expression.
Topics: Animals; Estrogens; Female; Hyperprolactinemia; Metoclopramide; Mice; Pituitary Gland; Progesterone; | 2013 |
Hyperprolactinemia changes the sulfated glycosaminoglycan amount on the murine uterus during the estrous cycle.
Topics: Animals; Biomarkers; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Estradiol; Estr | 2013 |
Effect of Chinese medical herbs-Huiru Yizeng Yihao on hyperprolactinemia and hyperplasia of mammary gland in mice.
Topics: Animals; Disease Models, Animal; Drugs, Chinese Herbal; Estradiol; Female; Gonadal Steroid Hormones; | 2013 |
Effects of hyperprolactinemia on the tibial epiphyseal plate of mice treated with sex hormones.
Topics: Androgens; Animals; Cartilage, Articular; Cell Proliferation; Disease Models, Animal; Dopamine D2 Re | 2016 |
Effects of metoclopramide-induced hyperprolactinemia on the prolactin and prolactin receptor expression of murine adrenal.
Topics: Adrenal Glands; Animals; Disease Models, Animal; Estradiol; Estrogens; Female; Hyperprolactinemia; I | 2015 |
Studies on the regulatory effect of Peony-Glycyrrhiza Decoction on prolactin hyperactivity and underlying mechanism in hyperprolactinemia rat model.
Topics: Animals; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Dopamine Plasma Membrane Transport | 2015 |
Influence of hyperprolactinemia on collagen fibers in the lacrimal gland of female mice.
Topics: Animals; Collagen; Estradiol; Female; Hyperprolactinemia; Lacrimal Apparatus; Metoclopramide; Mice; | 2015 |
Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia.
Topics: Adult; Dopamine D2 Receptor Antagonists; Female; Humans; Hyperprolactinemia; Metoclopramide; Middle | 2017 |
[Metoclopramide test in the patients with hyperprolactinemia due to end-stage renal failure].
Topics: Adult; Aged; Case-Control Studies; Female; Humans; Hyperprolactinemia; Kidney Failure, Chronic; Male | 2006 |
[Features of pituitary tumors and incidentalomas in hyper- and hypoprolactinemia].
Topics: Adult; Female; Humans; Hyperprolactinemia; Incidental Findings; Magnetic Resonance Imaging; Male; Me | 2008 |
Effects of metoclopramide-induced hyperprolactinemia on the prolactin receptor of murine endometrium.
Topics: Animals; Disease Models, Animal; Endometrium; Estradiol; Female; Gene Expression Regulation; Hormone | 2010 |
Casticin, a flavonoid isolated from Vitex rotundifolia, inhibits prolactin release in vivo and in vitro.
Topics: Animals; Cells, Cultured; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor alpha; Estr | 2010 |
Morphological and immunohistochemical comparison of three rat prostate lobes (lateral, dorsal and ventral) in experimental hyperprolactinemia.
Topics: Androgens; Animals; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Hyperprolactinemia; Image P | 2010 |
Effects of metoclopramide on the mouse anterior pituitary during the estrous cycle.
Topics: Animals; Cell Proliferation; Dopamine Antagonists; Estrous Cycle; Female; Hyperprolactinemia; Immuno | 2011 |
Not only dopamine D2 receptors involved in Peony-Glycyrrhiza Decoction, an herbal preparation against antipsychotic-associated hyperprolactinemia.
Topics: Animals; Bromocriptine; Cell Line; Disease Models, Animal; Dopamine; Dopamine D2 Receptor Antagonist | 2012 |
[The concentrations of prolactin and estrogens in women with fibrocystic changes in the breast].
Topics: Adult; Case-Control Studies; Estradiol; Estrogens; Estrone; Female; Fibrocystic Breast Disease; Foll | 2002 |
Antiprolactin autoantibodies are associated with hyperprolactinemic status in men infected with human immunodeficiency virus.
Topics: Adult; Aged; Autoantibodies; HIV Infections; Humans; Hyperprolactinemia; Male; Metoclopramide; Middl | 2002 |
Metoclopramide-induced hyperprolactinemia affects mouse endometrial morphology.
Topics: Animals; Dopamine Antagonists; Endometrium; Epithelium; Female; Hyperprolactinemia; Metoclopramide; | 2002 |
The expression of androgen receptors in the epithelial cells of the rat prostate lateral lobe in experimental hyperprolactinaemia: a morphological and immunohistochemical study.
Topics: Animals; Disease Models, Animal; Endoplasmic Reticulum, Rough; Epithelial Cells; Fluorescent Antibod | 2003 |
Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin.
Topics: Adult; Blotting, Western; Dopamine Antagonists; Female; Humans; Hyperprolactinemia; Hypothalamo-Hypo | 2004 |
Hyperprolactinemia in children during the peripubertal period--personal observations.
Topics: Adolescent; Age Factors; Amenorrhea; Biomarkers; Female; Galactorrhea; Gynecomastia; Humans; Hyperpr | 2004 |
[The effect of hyperprolactinemia on morphology and function of androgen receptor expressing cells in rat testis, epididymis and prostate].
Topics: Animals; Epididymis; Hyperprolactinemia; Male; Metoclopramide; Prolactin; Prostate; Rats; Rats, Wist | 2004 |
Morphology of the epithelial cells and expression of androgen receptor in rat prostate dorsal lobe in experimental hyperprolactinemia.
Topics: Animals; Dopamine Antagonists; Epithelial Cells; Hyperprolactinemia; Image Processing, Computer-Assi | 2006 |
Metoclopramide-induced hyperprolactinaemia caused marked decline in pinopodes and pregnancy rates in mice.
Topics: Animals; Disease Models, Animal; Endometrium; Female; Hyperprolactinemia; Metoclopramide; Mice; Preg | 2006 |
Development of anti-PRL (prolactin) autoantibodies by homologous PRL in rats: a model for macroprolactinemia.
Topics: Animals; Autoantibodies; Disease Models, Animal; Dopamine Antagonists; Epitopes; Estrous Cycle; Fema | 2007 |
Hyperprolactinaemia in a patient with cystic fibrosis.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Antiemetics; Cystic Fibrosis; Domperidone; Drug Combination | 2007 |
Effects of a dopamine antagonist (metoclopramide) on the release of beta-endorphin, ACTH and cortisol in hyperprolactinemic-amenorrheic women.
Topics: Adrenocorticotropic Hormone; Adult; Amenorrhea; beta-Endorphin; Dopamine Antagonists; Female; Humans | 1995 |
The effect of naloxone and metoclopramide on the secretion of luteinizing hormone in a hyperprolactinemic hypogonadotropic postmenopausal woman.
Topics: Aged; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Female; Follicle Stimulating Hormone; | 1995 |
Drug-induced hyperprolactinaemia.
Topics: Adult; Female; Humans; Hyperprolactinemia; Metoclopramide | 1994 |
Does hyperprolactinaemia predispose to aluminium toxicity in chronic renal failure?
Topics: Adult; Aluminum; Diabetic Nephropathies; Female; Humans; Hyperprolactinemia; Intestinal Absorption; | 1994 |
Different responses in little and bigbig prolactin to metoclopramide in subjects with hyperprolactinemia due to 150-170 kD (bigbig) prolactin.
Topics: Adult; Chromatography, Gel; Female; Follicular Phase; Humans; Hyperprolactinemia; Injections, Intrav | 1993 |
Prolactin response to metoclopramide and thyrotropin-releasing hormone in normoprolactinemic and hyperprolactinemic women: a comparison of diagnostic validity.
Topics: Adult; Dopamine Antagonists; Female; Humans; Hyperprolactinemia; Metoclopramide; Pituitary Gland; Pr | 1996 |
The influence of latent hyperprolactinaemia on the levels of LH, FSH, E2 and T in the midfollicular phase of the cycle.
Topics: Adolescent; Adult; Dopamine Antagonists; Estradiol; Female; Follicle Stimulating Hormone; Follicular | 1997 |
Persistent increase of PRL after oral contraceptive treatment. Alterations in dopaminergic regulation as possible etiology.
Topics: Adult; Contraceptives, Oral, Combined; Dopamine; Estradiol; Female; Humans; Hyperprolactinemia; Meto | 1999 |
Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemia.
Topics: Aged; Humans; Hyperprolactinemia; Levodopa; Male; Metoclopramide; Middle Aged; Neoplasm Metastasis; | 2000 |
Galactorrhoea, hyperprolactinaemia, and protease inhibitors.
Topics: Drug Therapy, Combination; Female; Fluoxetine; Galactorrhea; HIV Infections; HIV Protease Inhibitors | 2001 |
Germ cells with nuclear DNA fragmentation related to apoptotic cells in rat testis in experimental hyperprolactinemia induced by metoclopramide.
Topics: Animals; Apoptosis; Cell Nucleus; DNA Fragmentation; Dopamine Antagonists; Germ Cells; Hyperprolacti | 2002 |
[A case of functional hyperprolactinemia].
Topics: Adult; Amenorrhea; Female; Galactorrhea; Humans; Hyperprolactinemia; Metoclopramide; Neurotic Disord | 1992 |
[Drug-induced hyperprolactinemia and galactorrhea].
Topics: Adult; Female; Galactorrhea; Humans; Hyperprolactinemia; Metoclopramide; Prolactin | 1992 |
Monoamine regulation of prolactin and TSH secretion in hypothyroidism.
Topics: Adenoma; Adult; Cyproheptadine; Dopamine; Female; Humans; Hyperprolactinemia; Hypothyroidism; Metocl | 1992 |
Effects of nocturnal hyperprolactinemia on ovarian luteal function and galactorrhea.
Topics: Adult; Circadian Rhythm; Corpus Luteum; Female; Galactorrhea; Humans; Hyperprolactinemia; Luteinizin | 1991 |
[The value of functional tests in diagnosis of prolactinoma].
Topics: Circadian Rhythm; Female; Humans; Hyperprolactinemia; Metoclopramide; Pituitary Neoplasms; Prolactin | 1990 |
The metoclopramid-provocation test for prediction of transient hyperprolactinemia during cycle stimulation.
Topics: Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Humans; Hyperprolactinemia; Menstrual Cy | 1990 |
[Pharmacodynamic metoclopramide (cerucal) test in differential diagnosis of hypoprolactinemic hypogonadism syndrome in women].
Topics: Adult; Diagnosis, Differential; Female; Humans; Hyperprolactinemia; Hypogonadism; Metoclopramide; Pi | 1990 |
Arteriovenous shunting and cholestasis in hepatic hemangiomatosis associated with metoclopramide.
Topics: Adult; Angiography; Angiomatosis; Cholestasis; Female; Galactorrhea; Humans; Hyperprolactinemia; Liv | 1990 |
[The value of hyperprolactinemia determination within the scope of galactorrhea].
Topics: Adult; Female; Fibrocystic Breast Disease; Galactorrhea; Humans; Hyperprolactinemia; Lactation Disor | 1989 |
The effect of angiotensin-converting enzyme inhibition on prolactin responses in normal and hyperprolactinemic subjects.
Topics: Adult; Angiotensin II; Blood Pressure; Captopril; Diet; Diet, Sodium-Restricted; Female; Humans; Hyp | 1989 |
Suppression of serum immunoreactive human epidermal growth factor by acute increase in prolactin in women.
Topics: Adenoma; Adolescent; Adult; Epidermal Growth Factor; Female; Humans; Hyperprolactinemia; Metoclopram | 1989 |
Ultrastructure of epithelial cells in rat's epididymal caput in experimental hyperprolactinemia induced by metoclopramide.
Topics: Animals; Epididymis; Hyperprolactinemia; Male; Metoclopramide; Rats; Rats, Inbred Strains | 1989 |
Metoclopramide-induced hyperprolactinaemia: effects on corpus luteum function, endometrial steroid receptor concentrations and 17 beta-hydroxysteroid dehydrogenase activity.
Topics: 17-Hydroxysteroid Dehydrogenases; Adult; Corpus Luteum; Endometrium; Female; Humans; Hyperprolactine | 1987 |
Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states.
Topics: Adenoma; Adult; Amenorrhea; Antipsychotic Agents; Dopamine Antagonists; Endorphins; Female; Humans; | 1987 |
[Diagnostic value of pharmacological tests and roentgenoradiological methods in the diagnosis of various forms of hyperprolactinemic hypogonadism].
Topics: Adult; Amenorrhea; Female; Galactorrhea; Humans; Hyperprolactinemia; Lactation Disorders; Metoclopra | 1986 |
Pituitary-adrenocortical response to metoclopramide in patients with acromegaly and prolactinoma: a clinical evaluation of catecholamine-mediated adrenocorticotropin secretion.
Topics: Acromegaly; Adrenal Cortex; Adrenocorticotropic Hormone; Adult; Aged; Catecholamines; Corticotropin- | 1987 |
Dynamic evaluation of prolactin secretion by successive TRH and metoclopramide stimulations.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Humans; Hyperprolactinemia; Male; Metocloprami | 1986 |
The effect of cysteamine, cystamine, and the structurally related compounds taurine, N-acetyl-cysteine, and D-penicillamine on plasma prolactin levels in normal and estrogen-primed hyperprolactinemic rats.
Topics: Acetylcysteine; Animals; Cystamine; Cysteamine; Estradiol; Hyperprolactinemia; Male; Metoclopramide; | 1987 |
[Role of TRH or metoclopramide loading test in the diagnosis of so-called occult or latent hyperprolactinemia].
Topics: Adult; Bromocriptine; Circadian Rhythm; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing | 1987 |
[Prolactin stimulation using the metoclopramide test in females taking oral contraceptives].
Topics: Adult; Contraceptives, Oral, Hormonal; Female; Humans; Hyperprolactinemia; Metoclopramide; Prolactin | 1988 |
[The physiopathological aspects of the normoprolactinemic amenorrhea-galactorrhea syndrome].
Topics: Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Metoclopramide; Prolact | 1987 |
Defective dopaminergic regulation of prolactin secretion in patients with hyperprolactinemia.
Topics: Adenoma; Adult; Dopamine; Female; Humans; Hyperprolactinemia; Metoclopramide; Middle Aged; Pituitary | 1988 |
Metoclopramide-induced galactorrhea.
Topics: Adult; Female; Galactorrhea; Humans; Hyperprolactinemia; Lactation Disorders; Metoclopramide | 1987 |
Familial occurrence of big-big prolactin as the predominant immunoreactive human prolactin species in blood.
Topics: Adult; Female; Genotype; Haploidy; HLA Antigens; Humans; Hyperprolactinemia; Major Histocompatibilit | 1987 |
Plasma aldosterone response to metoclopramide is unmodified by hyperprolactinemia.
Topics: Adult; Aldosterone; Female; Humans; Hyperprolactinemia; Metoclopramide; Middle Aged; Pituitary Neopl | 1987 |
Hyperprolactinemia associated with chronic renal failure in the rat.
Topics: Animals; Bromocriptine; Cells, Cultured; Creatinine; Dopamine; Hyperprolactinemia; Kidney Failure, C | 1986 |
[The metoclopramide and nomifensine tests in the diagnosis of prolactinomas].
Topics: Diagnosis, Differential; Female; Humans; Hyperprolactinemia; Male; Metoclopramide; Nomifensine; Pitu | 1986 |
Parallelism in the luteinizing hormone responses to opioid and dopamine antagonists in hyperprolactinemic women with pituitary microadenoma.
Topics: Adenoma; Adult; Dopamine Antagonists; Female; Humans; Hyperprolactinemia; Luteinizing Hormone; Metoc | 1986 |
Aldosterone responsiveness to metoclopramide in hyperprolactinaemia.
Topics: Aldosterone; Female; Humans; Hyperprolactinemia; Metoclopramide; Prolactin; Thyrotropin | 1987 |
Responses of growth hormone to metoclopramide in normal women and amenorrheic women with or without hyperprolactinemia.
Topics: Adult; Amenorrhea; Estradiol; Female; Growth Hormone; Humans; Hyperprolactinemia; Injections, Intrav | 1986 |
Treatment of hyperprolactinemic amenorrhea with Metergoline.
Topics: Adenoma; Adult; Amenorrhea; Ergolines; Female; Humans; Hyperprolactinemia; Metergoline; Metocloprami | 1986 |
Twenty-four hour secretory pattern of thyroid-stimulating hormone in hyperprolactinemic women with pituitary microadenoma.
Topics: Adenoma; Adult; Circadian Rhythm; Female; Humans; Hyperprolactinemia; Metoclopramide; Pituitary Glan | 1985 |
Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients.
Topics: Adenoma; Adolescent; Adult; Diagnosis, Differential; Empty Sella Syndrome; Female; Humans; Hyperprol | 1985 |
[Radiological and endocrinological evaluation of 36 hyperprolactinemic women].
Topics: Adult; Female; Humans; Hyperprolactinemia; Metoclopramide; Ovulation; Prolactin; Radiography; Sella | 1985 |